FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Golden State Medical Supply Enalapril Maleate Tablets Recall

Enalapril Maleate Tablets, USP

Golden State Medical Supply Inc. · Camarillo, CA

Risk level
Class II
Reported by FDA
Jul 13, 2022
Recall ID
D-1179-2022
Check your lot numberHow we source this data

Summary

Golden State Medical Supply recalled Enalapril Maleate Tablets starting Mar 16, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1179-2022 on Jul 13, 2022. Reason: CGMP Deviations. Status: Ongoing.

Why it was recalled

CGMP Deviations

Product description

Enalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.

Lot numbers, UPCs & expiration codes

Lots: GS027890, GS028177, GS028488, 10 mg; 90 tablets, Exp.: 04/2022; Lots: GS028847, GS028848, Exp.: 09/2022; GS029627, GS029862,GS030057, GS030481, GS030870, GS031060, GS031437, GS031438, GS033527, GS034231, Exp.: 10/2022; Lots: GS034810, Exp.: 01/2023; Lots: GS035240, GS035598, Exp.: 05/2023; Lots: GS036194, Exp.: 06/2023; Lots: GS036760, GS036981,GS037526, GS038177, GS038728, Exp.: 08/2023; Lots: GS038729, GS041108, Exp.: 09/2023; Lots: GS039412, GS039840, GS041109, Exp.: 12/2023; Lot: GS041655, Exp.: 01/2024; Lot: GS041656, Exp.: 05/2024. (NDC: 60429-185-90).

Where it was sold

Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1179-2022
Classification
Class II
Status
Ongoing
Recall initiated
Mar 16, 2022
FDA report date
Jul 13, 2022
Quantity
31,260 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Golden State Medical Supply Inc.

Original FDA data

Every field from FDA enforcement report D-1179-2022, exactly as published.

Show all FDA fields
City
Camarillo
State
CA
Status
Ongoing
Country
United States
Event ID
89863
Address
5187 Camino Ruiz
Code information
Lots: GS027890, GS028177, GS028488, 10 mg; 90 tablets, Exp.: 04/2022; Lots: GS028847, GS028848, Exp.: 09/2022; GS029627, GS029862,GS030057, GS030481, GS030870, GS031060, GS031437, GS031438, GS033527, GS034231, Exp.: 10/2022; Lots: GS034810, Exp.: 01/2023; Lots: GS035240, GS035598, Exp.: 05/2023; Lots: GS036194, Exp.: 06/2023; Lots: GS036760, GS036981,GS037526, GS038177, GS038728, Exp.: 08/2023; Lots: GS038729, GS041108, Exp.: 09/2023; Lots: GS039412, GS039840, GS041109, Exp.: 12/2023; Lot: GS041655, Exp.: 01/2024; Lot: GS041656, Exp.: 05/2024. (NDC: 60429-185-90).
Postal code
93012-8601
Report date
Jul 13, 2022
Product type
Drugs
Recall number
D-1179-2022
Classification
Class II
Recalling firm
Golden State Medical Supply Inc.
Product quantity
31,260 bottles
Reason for recall
CGMP Deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Enalapril Maleate Tablets, USP; 10 mg; 90 tablets, NDC 60429-185-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA.
Distribution pattern
Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI
Recall initiation date
Mar 16, 2022
Initial firm notification
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
Center classification date
Jul 7, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1179-2022, published Jul 13, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls